smoking cessation

Pharmacotherapies for COPD.

Pharmacotherapies for COPD.

Clin Med Insights Circ Respir Pulm Med. 2013; 7: 17-34
Ejiofor S, Turner AM

This review article summarizes the main treatments for chronic obstructive pulmonary disease, their mechanisms, and the key evidence from trials supporting their… Continue reading →

Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure: Background, Aims and Design of the RACE 3 Study.

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study.

Neth Heart J. 2013 May 23;
Alings M, Smit MD, Moes ML, Crijns HJ, Tijssen… Continue reading →

Assay Sensitivity and Study Features in Neuropathic Pain Trials: An ACTTION Meta-Analysis.

Assay sensitivity and study features in neuropathic pain trials: An ACTTION meta-analysis.

Neurology. 2013 May 22;
Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Farrar JT, Katz NP, Lin AH, Rappaport BA, Rowbotham MC

OBJECTIVE: Our objective… Continue reading →

The Effects of Acute Abstinence From Smoking and Performance-Based Rewards on Performance Monitoring.

The effects of acute abstinence from smoking and performance-based rewards on performance monitoring.

Psychopharmacology (Berl). 2013 May 17;
Schlienz NJ, Hawk LW, Rosch KS

RATIONALE: Abstinence from smoking disrupts performance in multiple cognitive domains, and such cognitive effects may… Continue reading →

Rehabilitation Protocol for Patellar Tendinopathy Applied Amongst 16-19 Year Old Volleyball Players.

Rehabilitation protocol for patellar tendinopathy applied amongst 16-19 year old volleyball players.

J Strength Cond Res. 2013 May 9;
Biernat R, Trzaskoma Z, Trzaskoma L, Czaprowski D

The aim of the study was to investigate the efficacy of rehabilitation… Continue reading →

Fifty-Two-Week Continuous Abstinence Rates of Smokers Being Treated With Varenicline Versus Nicotine Replacement Therapy.

Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.

Addiction. 2013 May 13;
Kralikova E, Kmetova A, Stepankova L, Zvolska K, Davis R, West R

BACKGROUND AND AIMS: Cross-study comparisons of effect sizes suggest… Continue reading →

Social and Emotional Processing as a Behavioural Endophenotype in Eating Disorders: A Pilot Investigation in Twins.

Social and Emotional Processing as a Behavioural Endophenotype in Eating Disorders: A Pilot Investigation in Twins.

Eur Eat Disord Rev. 2013 May 7;
Kanakam N, Krug I, Raoult C, Collier D, Treasure J

OBJECTIVES: Emotional processing difficulties are potential… Continue reading →

Brain Nitric Oxide Metabolites in Rats Preselected for Nicotine Preference and Intake.

Brain Nitric Oxide Metabolites in Rats Preselected for Nicotine Preference and Intake.

Neurosci Lett. 2013 Apr 30;
Keser A, Nesil T, Kanit L, Pogun S

Nicotine addiction is a serious health problem resulting in millions of preventable deaths worldwide.… Continue reading →

Producing the “Problem” of Addiction in Drug Treatment.

Producing the “Problem” of Addiction in Drug Treatment.

Qual Health Res. 2013 May 3;
Moore D, Fraser S

In this article, we argue that the “problem” of addiction emerges as an effect of treatment policy and practice as well… Continue reading →

Suboxone Pharma Foibles/FDA Does Its Job Well.

Suboxone Pharma Foibles/FDA Does Its Job Well.

R I Med J (2013). 2013; 96(4): 13
Gordon A, Kretzschmar A, Gilbert E

HubMed – addiction

 

Pyrvinium targets autophagy addiction to promote cancer cell death.

Cell Death Dis. 2013;… Continue reading →